HEVERT GELSEMIUM COMP- aconitum napellus, anamirta cocculus seed, citrullus colocynthis fruit, gelsemium sempervirens root, lach

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

ACONITUM NAPELLUS WHOLE (UNII: U0NQ8555JD) (ACONITUM NAPELLUS WHOLE - UNII:U0NQ8555JD), ANAMIRTA COCCULUS SEED (UNII: 810258W28U) (ANAMIRTA COCCULUS SEED - UNII:810258W28U), CITRULLUS COLOCYNTHIS FRUIT (UNII: 0E49E3V9U6) (CITRULLUS COLOCYNTHIS FRUIT - UNII:0E49E3V9U6), GELSEMIUM SEMPERVIRENS ROOT (UNII: 639KR60Q1Q) (GELSEMIUM SEMPERVIRENS ROOT - UNII:639KR60Q1Q), LACHESIS MUTA VENOM (UNII: VSW71SS07I) (LACHESIS MUTA VENOM - UNII:VSW71SS07I), DAPHNE MEZEREUM BARK (UNII: X2N6E405GV) (DAPHNE MEZEREUM BAR

Available from:

Hevert Pharmaceuticals LLC

INN (International Name):

ACONITUM NAPELLUS

Composition:

ACONITUM NAPELLUS 4 [hp_X] in 2 mL

Administration route:

INTRAVENOUS

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

1.1 Hevert® Gelsemium comp. is a homeopathic drug indicated for the improvement of painful nerve conditions, such as postherpetic neuralgia, trigeminal neuralgia, or sciatic nerve pain. Hevert® Gelsemium comp. is contraindicated in patients with known hypersensitivity to Rhus toxicodendron or other plants from the cashew family, or to any of its ingredients. Animal reproduction studies have not been performed with Hevert® Gelsemium comp. or any of its ingredients. There are not adequate and well-controlled studies in pregnant women. Hevert® Gelsemium comp. should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. No non-teratogenic effects are known. No recognized use in labor or delivery. It is not known whether Hevert® Gelsemium comp. is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Hevert® Gelsemium comp. is administered to a nursing woman. Safety and effectiveness in elderly patients (≥65 years

Authorization status:

unapproved homeopathic

Summary of Product characteristics

HEVERT GELSEMIUM COMP- ACONITUM NAPELLUS, ANAMIRTA COCCULUS SEED,
CITRULLUS COLOCYNTHIS FRUIT, GELSEMIUM SEMPERVIRENS ROOT, LACHESIS
MUTA
VENOM, DAPHNE MEZEREUM BARK, STRYCHNOS NUX-VOMICA SEED, LEAD ACETATE
ANHYDROUS, AND TOXICODENDRON PUBESCENS SHOOT INJECTION
HEVERT PHARMACEUTICALS LLC
_Disclaimer: This homeopathic product has not been evaluated by the
Food and Drug_
_Administration for safety or efficacy. FDA is not aware of scientific
evidence to support_
_homeopathy as effective._
----------
HEVERT GELSEMIUM COMP.
HIGHLIGHTS OF PRESCRIBING
INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE
INFORMATION NEEDED TO USE HEVERT
GELSEMIUM COMP. SAFELY AND
EFFECTIVELY.
SEE FULL PRESCRIBING INFORMATION FOR
HEVERT
GELSEMIUM COMP.
Hevert
Gelsemium comp. solution for
injection, for intramuscular, subcutaneous,
and intracutaneous administration.
Rx Use Only
------------- INDICATIONS AND USAGE --
-----------
Hevert
Gelsemium comp. is a
homeopathic drug indicated for the
improvement of painful nerve conditions,
such as postherpetic neuralgia, trigeminal
neuralgia, or sciatic nerve pain. (1)
--------- DOSAGE AND
ADMINISTRATION ---------
Standard Dosage:
ADULTS:
1 mL to 2 mL 1 to 3 times per 7 days.
Acute Dosage:
ADULTS:
1 mL to 2 mL up to 3 times daily.
Hevert
Gelsemium comp. may be
-------- DOSAGE FORMS AND
STRENGTHS --------
One ampule containing 2 mL solution for
injection, containing the active
ingredients in the strengths listed under
Description. (3)
---------------- CONTRAINDICATIONS ----
------------
Hevert
Gelsemium comp. is
contraindicated in patients with known
hypersensitivity to Rhus toxicodendron
or other plants from the cashew family,
or to any of its ingredients. (4)
--------- WARNINGS AND PRECAUTIONS
---------
Keep out of reach of children. (5)
---------------- ADVERSE REACTIONS ----
------------
No adverse events have been reported
with causal relationship to Hevert
Gelsemium comp. (6.1)
TO REPORT SUSPECTED ADVERSE
REACTIONS, CONTACT HEVERT
PHARMACEUTICALS AT 1-855-387-6466
OR FDA AT 1-800-FDA-1088 OR
WWW